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Regulation of atrial natriuretic peptide receptors in glomeruli during
chronic salt loading. The effects of chronic salt loading on atrial
natriuretic peptide (ANP) receptor density and affinity were studied in
isolated renal glomeruli of male Sprague-Dawley rats, which received
0.9% saline as drinking fluid (NaCI-rats) and a normal rat chow diet for
35 days (N = 12). Animals on a low sodium intake received the same
diet, but deionized water and served as controls (C) (N = 12). After 35
days blood pressure was only slightly increased to 136 9 in NaCI-rats
versus 120 2 mm Hg in C (NS). Glomerular filtration rate, plasma
cGMP and plasma ANP remained unaltered. Determination of total
ANP receptor characteristics in these rats indicated a significant
down-regulation of ANP receptors in salt loaded rats. Since ANP-
stimulated cGMP formation was not affected by salt loading, the roles
of clearance (C) and of biologically active (B) receptors were further
evaluated at 21°C on freshly isolated and acid washed (pH 5) glomeruli
in seven animals after 35 days of salt loading and in seven animals on a
low sodium intake. 8-receptors were assessed by blocking C-receptors
with 4-23 cANP. C-receptor numbers were lower in NaCI-rats (97 8
vs. 184 14 fmol/mg protein in C; N = 7; P < 0.02), while C-receptor
affinity was increased (Kd: 12 3 pi in NaC1-rats vs. 22 5 pti in C;
P < 0.02). Binding sites of B-receptors did not significantly change with
high sodium intake (211 16 in NaCI-rats vs. 244 21 fmol/mg
protein), but B-receptor affinity was moderately reduced (Kd: 529 27
in NaCI-rats vs. 437 14 M in C; P < 0.02). Thus, the decrease in total
ANP receptors after salt loading was exclusively due to a decrease in
C-receptors. During chronic high sodium intake, down-regulation of
C-receptors for ANP may indirectly enhance ANP-binding to biologi-
cally active B-receptors for ANP within the rat kidney to promote
sodium excretion in the absence of augmented circulating ANP.
There is a large body of evidence suggesting that atrial
natriuretic peptide (ANP) is involved in the regulation of
electrolyte balance, extracellular fluid volume (ECFV) and
blood pressure (BP). Thus, circulating ANP was demonstrated
to have potent diuretic, natriuretic [1], vasorelaxant [2, 31, and
aldosterone-inhibiting properties [4, 5]. In addition, ANP is
presumed to serve as a neuromodulator or neurotransmitter
substance within the brain and to influence central fluid and BP
regulating mechanisms by acting on receptors in the circumven-
tricular organs [reviewed in 6].
Following acute or chronic ECFV expansion [7—9] associated
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with atrial distention [10, 11], ANP is released into the circula-
tion to exert its effects via specific receptors in the kidney,
adrenal gland, vascular smooth muscle and other target organs.
More recently, glomerular ANP receptors in the rat were
shown to vary inversely with circulating levels of ANP [12], and
to be dependent in density and affinity on alterations in sodium
intake [13, 14]. Only limited information, however, is available
regarding sequential changes in receptor regulation as related to
concomitant alterations in plasma ANP concentrations and
renal functional changes. Thus, the present study was under-
taken to examine time-dependent rat glomerular ANP receptor
regulation during chronic salt loading as well as associated
changes in systemic hemodynamics and renal function. Further
studies were performed using 4-23 cANP in order to elaborate
the potential involvement of biologically-inactive clearance (C-)
ANP receptors.
Methods
Experimental protocol
A first series of experiments was performed in two groups of
12 male Sprague-Dawley rats each, which were placed either on
a high or low sodium intake for 35 days. In addition, in each
group eight rats were studied on day 2 and six rats on day 10 of
the dietary regimens. Animals on a high sodium intake (NaCl-
rats) received a normal rat chow diet (Altromin' International,
Lage, FRG; 0.2% Na; 0.6% K) and 0.9% saline as drinking
fluid. Animals on the low sodium intake (C) received the same
rat chow diet but deionized water as drinking fluid. All rats were
kept in metabolic cages and systolic blood pressure (BP) and
24-hour urine output were determined daily for the first seven
days and every third day, thereafter. Systolic BP was measured
by tail-cuff plethysmography.
In a second series of experiments seven additional NaCl-rats
and seven control rats were maintained on the same dietary
regimen as above for 35 days. They served for detailed studies
of ANP receptors in fresh glomeruli that were acid washed to
minimize ANP receptor preoccupancy.
Average sodium intake ranged between 9.7 and 12.3 mmoII24
hr in NaC1-rats and between 1.4 and 1.7 mmol/24 hr in C. The
increase in body weight during the study period did not differ
between the two groups; both revealed a final average body
weight of approximately 370 g. The single kidney weight at day
35 averaged 1.22 0.05 g in NaCl-rats and 1.15 0.05 g in
74 Michel et a!: Na loading effect on ANP receptors
controls (N = 19; NS). At the end of the study (day 35) blood
and 24 hour urine were collected for measurements of plasma
ANP and cGMP concentrations, urine sodium excretion and
estimation of glomerular filtration rate (GFR) by endogenous
creatinine clearance. Rats were killed between 8.00 and 9.00
a. m.
Isolation of glomeruli
Rat renal glomeruli were isolated as described by Ballermann
et al [13]. In brief, renal cortical tissue from individual animals
was gently passed through a stainless steel sieving system, with
mesh sizes of 150, 100 and 75 jsm. The tissue sieving was
performed under frequent rinsing with ice-cold phosphate-
buffered saline (PBS; mM; NaCI, 137; Na2HPO4 .2 H20, 5.62;
NaH2PO4 . H20, 1.09; KCI, 2.7; KH2PO4, 1.47; pH 7.2).
Glomeruli were collected from the 75 sm sieve into a 30 ml
centrifuge tube and were washed twice in PBS by centriluga-
tion; the centrifuge was stopped immediately upon reaching
2,000 rpm. Finally, glomeruli from animals of the first series of
experiments were suspended in exactly 7 ml of Hank's balanced
salt solution (HBSS, mM: NaC1, 137; KCI, 5.4; KH2PO4, 0.44;
Na2HPO4, 0.33; MgSO4, 0.40; MgCI2, 0.50; CaCI2, 1.25;
NaHCO3, 4.0; pH 7.38) and a 0.4 ml aliquot was taken for
protein measurement [15]. For binding studies these glomeruli
were kept frozen at —70°C until assay. For the binding assay,
the glomerular suspension was supplemented with bovine se-
rum albumin (BSA; 200 mg/dl), Hepes 10 m, glucose 5.5 mri,
bacitracine 1 m, and phenylmethylsufonyl-fluoride 1 mrt, pH
7.28.
Fresh glomeruli from animals of the second series of exper-
iments were isolated as described above and were resuspended
at pH 5 in PBS (10 mm) for the second centrifugation. Acidifi-
cation to pH 5 was applied to minimize potential receptor
preoccupation of glomeruli. Glomeruli were finally suspended
in a solution modified to that described by Gauquelin et al [15],
supplemented with BSA (200 mgld) and containing Tris-HCI 50
mM, NaC1 90 msi, MgCI2 5 mM, aprotinin 1 pM, bacitracine 1
m, and phenylmethylsulfonyl-fluoride 1 m'vi, pH 7.28.
Receptor assay
Receptor binding at 0°C without acid wash. Competitive
binding inhibition studies were performed according to the
method of Ballermann et al [13] at 0°C. Fifty microliters of each
1251-rANP (15 to 20 fmol, approx. 80,000 dpm) and varying
concentrations of unlabeled ANP (10 M to 10 M) were
given into incubation tubes. Incubation was started by adding
400 d of glomerular suspension. Unspecific binding was calcu-
lated as cpm measured in the presence of saturating ANP
concentrations (106 M). After 120 minutes, incubation was
stopped with 2 ml of ice-cold PBS. Bound and free ligand were
separated by rapid filtration through Whatman' GF/C-filters,
pretreated with 0.33% polyethylenimine (PEI). Filtration was
performed in a MilliporeR filtration unit, holding 12 filters.
Filters were rinsed three times with 3 ml ice-cold PBS. Filters
were then allowed to dry and radioactivity was counted in a
Kontron gamma counter with 80% efficiency. Total binding
averaged 5 to 10% of radioactivity added and unspecific binding
was approximately 1% of total counts. Total binding was not
enhanced by an acid wash before incubation.
Study of C-receptor blocking in fresh acid-washed glomeruli.
Studies of C-receptor blocking were performed as competitive
binding inhibition (7 to 10 fmol, approx. 40,000 dpm) and
binding saturation experiments with freshly isolated glomeruli
for 70 minutes at 21°C. Binding equilibrium was reached after
approximately 50 minutes and remained stable for at least 30
minutes. For binding saturation studies glomeruli were incu-
bated with increasing concentrations of 1251-labeled rANP from
20 to 600 M (specific activity 200 to 250 Cilmmol). Binding
assays were performed with or without saturating concentra-
tions of 4-23 cANP (5 iO M) to distinguish total and
C-receptor-blocked ANP receptors.
Binding of 4-23 cANP was specific and revealed characteris-
tic binding profiles in a dose- and time-dependent manner (data
not shown). Total binding (B0) averaged 30% of radioactivity in
the absence of unlabeled ANP. Total binding was reduced by
approximately 30% when glomeruli were incubated at 21°C
without prior acid wash. Receptor internalization was consid-
ered to be insignificant since additional acid wash after incuba-
tion revealed a 5% retention of radioactivity at both 21°C and
0°C.
No evidence for proteolytic degradation of the ligand was
found when ANP was recovered by reversed-phase HPLC after
incubation with glomeruli (Fig. 1). For this purpose gloinerular
suspensions were incubated for 120 minutes at 0°C (Fig. 1B) and
for 70 minutes at 21°C (Fig. LD) with i0— M unlabeled 1-28
rANP. After incubation glomeruli were acid-washed and re-
moved by centrifugation. One hundred microliters of the super-
natant were subjected to RP-HPLC. For control, Figure 1A
shows the RP-HPLC profile of supernate from the incubation of
glomeruli at 21°C in the absence of rANP. Figure 1C shows the
elution of rANP when added to the supernatants after glomeruli
had been incubated for 70 minutes at 21°C and were removed by
centrifugation. Figure lB and D show the elution profile of
supernatant when glomeruli were incubated in the presence of
rANP. The rANP peaks of incubates at 0°C for 120 minutes (B)
and at 21°C for 70 minutes (D) do not differ significantly. rANP
peaks of both incubates B and D were smaller than the control
peak in incubate C in which no loss of rANP by unspecific
binding to glomeruli occurred.
In a second series of experiments '251-labeled rANP (10° M,
1,000 Ci/mmol) was added to the incubates. After incubation
with glomeruli at 21°C for 70 minutes, 86% of total counts were
recovered between minutes 29 and 31, and another 7% between
minutes 39 and 41 when supernates were subjected to RP-
HPLC (Fig. 1D, shaded bar). When 1251-rANP was added to
incubates after removal of glomeruli which had been incubated
at 21°C for 70 minutes 90% of total counts were detected
between minutes 29 and 31, and another 4% between minutes 39
and 41 (Fig. 1C, shaded bar). These results for recovery of
'251-rANP again do not provide evidence for significant proteo-
lytic degradation of the ligand in glomerular incubates at 21°C
for 70 minutes.
Cyclic guanosine monophosphate (cGMP) formation
Freshly isolated acid washed glomeruli were preincubated at
37°C for 15 minutes in 400 .tl of assay buffer. Isobuthyl-
methyl-xanthine (IBMX) was then added at a final concentra-
tion of 0.5 m to inhibit phosphodiesterase. cGMP formation
was initiated after two minutes of incubation with rANP for
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Fig. 1. Reversed phase HPLC (RP-HPLC) of unlabeled rANP and of
'25!-rANP in supernatants from glomerular incubates. Chromatograms
of supernatants from glomeruli incubated without ANP (A) for 70 mm at
21°C, (B) for 120 mm at 0°C with ANP, (C) for 70 mm at 21°C and
addition of ANP after incubation was stopped and glomeruli were
removed, (D) for 70 mm at 21°C with ANP. Recovery of '251-rANP
when added to glomeruli after 70 mm of incubation at 21°C (C) and
when added to glomeruli before incubation for 70 mm at 21°C (D).
RP-HPLC was performed as follows: RP-l8 column; Eluent A: 0.05%
TFA/H20 (vol/vol) pH 2.22; Eluent B: 60% CH3CN/0.05% TFA (you
vol) pH 2.22; A-B linear gradient (60 mm; I mllmin) UV-detection 220
nm; 2.56 AUFS.
dose- and time-related studies. Reaction was terminated with
500 i1 12% trichloroacetic acid (TCA) and subsequent ultrason-
ification. After centnfugation (15 mm at 2,000 g) the supernatant
was washed five times with 2 ml of diethylic ether. For storage,
cGMP containing medium was dried at 80°C in a water bath
under streamed air. After the dried incubate was resuspended in
0.5 ml of acetate buffer, 0.1 ml of suspension was used for
radioimmunoassay of cGMP.
'251-labeled rat atnal natriuretic peptide ('251-rANP) was
obtained from NEN Dupont Research Products (Boston, Mas-
sachusetts, USA), with a radiochemical purity of 97% and a
specific activity of 2,200 Cilmmol. Unlabeled 1-28 rANP and
4-23 cANP were purchased from Peninsula Laboratories (Maid-
enhead, England, UK).
Concentrations of cGMP in plasma and incubation media
were determined with a specific radioimmunoassay kit (DRG
Instruments, Marburg, FRG). All other chemicals were pur-
chased from Serva (Heidelberg, FRG) or Merck (Darmstadt,
100 FRG).
Plasma ANP concentration was determined by radioimmu-
noassay as previously described [16]. The high plasma ANP
concentrations which we had previously observed in our rats
clearly depended on the method of sacrificing the animals.
50 Thus, when animals were killed under light ether anesthesia,
plasma ANP concentration averaged 501 54 pa'i on the normal
rat chow diet (N = 12); it averaged 206 44 pi when rats were
killed by a blow on the head without anesthesia (N = 5) and it
0 averaged 39 5 p when blood was drawn under anesthesia
with pentobarbital (60 mg/kg; N = 7).
Serum and urinary concentrations of sodium were deter-
mined by flame photometry. Serum creatinine was measured by
a conventional autoanalyzer method. Urine creatinine was
analyzed after adsorption to Lloyds reagents. All determina-
tions were performed in duplicate.
Data analysis
100 All data are presented as means SEM for the indicated
number of animals. Statistical comparison of experimental
groups was performed using Student's two-tailed I-test for
unpaired data. A P value of less than 0.05 was considered as
50 statistically significant. Biologically active B-receptors afterblockade of C-receptors were considered to be homogenous.
Binding data were then determined by Scatchard analysis of
competitive binding inhibition and saturation data, using least
squares linear-regression method.0 Accordingly, total- and C-receptor characteristics were esti-
mated from binding saturation and from Scatchard plot using
non-linear regression of total binding data.
Results
Scatchard analysis of binding data obtained from the first
series of experiments resulted in nearly linear plots suggesting a
single homogenous receptor population. Maximal binding and
dissociation constant were significantly lower after 35 days of
high salt intake (Bmax: 110 4 vs. 305 15 fmollmg protein; P
< 0.001 in NaC1-rats and C, respectively; N = 12). This
down-regulation of ANP receptors was already observed after 2
(N = 8) and 10 (N 6) days of high salt intake (data not shown).
B- and C-receptor regulation
The second series of experiments carried out in fresh acid-
washed glomeruli, revealed similar alterations in total receptor
density after chronic salt loading but the absolute number of
binding sites was higher than in frozen glomeruli which were
not acid washed.
The data of the C-receptor blocking studies are illustrated in
Figure 2. Scatchard analysis of binding data resulted in a
concave-formed curve which is typical for the presence of
different distinct receptor types. Figure 3 shows a repre-
sentative Scatchard plot of glomerular ANP binding under
control conditions. ANP receptor number after C-receptor
blockade was about 60% of total ANP receptors. These remain-
ing ANP receptors probably are identical with biologically
active (B-) receptors and were not decreased after chronic salt
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Fig. 2. Biologically active (B)- and clearance (C)- ANP receptors in
freshly isolated and acid-washed glomeruli from rats after 35 days of
salt loading (iJ) as compared to controls (U). Blockade ofC-receptors
was performed in presence of 5 1O M 4-23 cANP. Binding studies
were carried out as competitive binding inhibition and as binding
saturation studies (N = 7; mean sEM). * P < 0.02
loading (211 16 vs. 244 21 fmol/mg protein in C). Their
affinity, however, was slightly decreased (K 529 27 vs. 437
14 M in C; P < 0.02).
Extrapolation of C-ANP receptors revealed a significant
decrease in C-receptor number (97 8 in NaCI vs. 184 14
fmol/mg protein in C; P < 0.02). The relatively high affinity of
C-receptors was even more pronounced after salt loading (12
3 in NaCl vs. 22 5 p in C; P <0.02).
Glomerular cGMP formation
Basal glomerular cGMP formation was similar in NaCl-rats
and in C and no differences in ANP dose-related (Fig. 4A) as
well as time-dependent (Fig. 4B) cGMP synthesis were ob-
served. In both groups of animals cGMP formation began to
increase at ANP concentrations of approximately 5 x lO M
and rose progressively thereafter with increasing concentra-
tions of ANP up to 10—6 M. Maximal ANP-stimulated (10—6 M
ANP) cGMP formation was observed between one and two
minutes after incubation was started. cGMP formation was not
stimulated by 4-23 cANP and rANP (5 x 108 M)-stimulated
cGMP formation was not affected in the presence of 4-23 cANP
(5 x 108 M) (data not shown).
Effects of chronic salt loading on plasma ANP, blood
pressure and GFR
Table 1 summarizes the data on plasma ANP and cGMP
concentrations, urinary sodium and cGMP excretion, and GFR
alter chronic salt loading. At day 35 plasma ANP concentration
was 39 5 pM in NaC1-rats and 38 3 pti in controls, when rats
were sacrificed under pentobarbital anaesthesia (N =7). Sys-
tolic BP (136 9 in NaCI-rats vs. 120 2 mm Hg in C; NS; N
= 12) was slightly increased as compared to the control group
without reaching statistical significance. Statistical comparison
of NaCl- and C-rats revealed no significant differences concern-
ing GFR and urinary cGMP excretion.
Discussion
The present study was designed to investigate the long-term
regulation of rat glomerular ANP receptors in response to
chronic salt loading. Potential alterations in systemic hemody-
ANP bound, fmo/
Fig. 3. Representative Scatchard plot of ANP binding in freshly iso-
lated and acid-washed glomeruli from a control rat. The plot of total
ANP binding was fitted from competitive binding inhibition data using
non-linear regression. Bm.x and Kd of B-receptors were determined
after blockade of C-receptors with 4-23 cANP (5. l0 M), using least
squares linear regression method. The plot of C-receptors was extrap-
olated from total- and B-receptor characteristics. Symbols are: (—)
total ANP receptors; (-.-) plot estimated for C-receptors (Kd —30 pM).
namics and renal function were examined with respect to
receptor-mediated physiological effects of ANP.
The present results demonstrate that total glomerular ANP
receptor density is down-regulated during 35 days of high salt
intake with differential effects on receptor types, that is, bio-
logically active (B-) receptors and inactive clearance (C-) re-
ceptors of ANP, and on receptor affinity depending in part on
the methods employed. Plasma ANP did not change signifi-
cantly with chronic salt loading. There were no significant
alterations in renal function, and blood pressure increased only
insignificantly after 35 days of salt loading. This may have been
expected since Sprague-Dawley rats represent a salt-resistant,
normotensive strain.
Recently, glomerular ANP receptor regulation has been the
objective of a series of investigations. ANP receptor alterations
were examined during dietary salt loading [13] or other ma-
nipulations of sodium balance [12] and in volume-dependent
and -independent models of hypertension [17—20]. Ballermann
et al [13] first showed a significant down-regulation of glomer-
ular ANP receptor density alter 10 to 14 days of salt loading. In
the majority of studies investigating the effects of changes in
sodium balance, the decrease in number of ANP binding sites
was associated with elevated plasma ANP levels [12, 18, 21]. It
was previously shown that changes in concentrations of various
peptide hormones are accompanied by inverse changes in
density of their specific receptors [22, 23]. Thus, elevated
plasma ANP levels were presumed, too, to present at least one
determinant for the down-regulation of receptor density.
In our study, however, no significant rise in plasma ANP was
observed after 2, 10 or 35 days of salt loading, but ANP receptor
density was markedly decreased. Unaltered plasma ANP con-
centrations after high salt intake were also reported by Luft et
al [24], whereas Lattion et al reported a rise in circulating ANF
levels after one week of salt loading (1% saline as drinking fluid)
which had disappeared after three weeks of a continuous high
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Table 1. Plasma ANP and cGMP concentrations, serum Na
concentrations. glomerular filtration rate (GFR), and urinary
excretion of sodium (UNaV) and of cGMP in rats after 35 days of salt
loading as compared to controls (low sodium)
Control
group NaCl-group
Plasma ANP pmol/liter; N = 7 38 3 39 5
Plasma cGMPpmol/ml; N = 12 10.6 1.0 12.0 1.4
Serum Na mmol/liter; N = 12 143.4 0.8 144.7 1.4
GFR .dImin/g kidney wt; N = 12 810 24 856 22
UNaV m,nol/24 hr; N = 12 1.80 0.10 10.05 0.70a
Urine cGMP mmol/24 hr; N = 12 36 7 41 7
Data are presented as means SEM.
a P < 0.001 NaC1 vs. control
sodium intake [25]. It has been suggested that increased atrial
pressure resulting from enhanced water intake may stimulate
ANP secretion [25]; however, we did not observe an increment
of plasma ANP in any phase of sodium loading, despite nearly
twofold higher drinking volumes in the salt loaded rats.
Since particulate guanylate cyclase presumably mediates the
renal and vascular actions of ANP [26], we measured cGMP
formation in glomeruli in response to ANP stimulation. ANP-
stimulated cGMP formation revealed a clear time- and dose-
response, but there were no differences between salt loaded and
control rats. These results are consistent with those obtained by
others [13, 27]. Unaltered cGMP formation in glomeruli of salt
loaded rats despite marked receptor alterations may suggest
involvement of functionally inactive receptor types.
Recent experimental evidence indeed suggests the existence
of at least two receptor types for ANP in the glomerulus
[27—31], namely B-receptors and C-receptors, that is, biologi-
cally active and silent or clearance receptors, respectively.
From a study in Dahl salt-sensitive and -resistant rats, Hinko,
Thibonnier and Rapp [27] conclude that the receptor undergo-
ing salt-induced alteration in binding kinetics is likely to be the
one not linked to cGMP. This low molecular weight receptor
seems to be identical with the type C or clearance receptor and
is not linked to particulate guanylate cyclase. Most recent data
suggest that this receptor is essentially affected by altered salt
intake [30]. The high molecular weight receptor as the biologi-
cally active receptor, in contrast, mediates cGMP production
[31]. Our findings that sodium loading affects total receptor
density but does not affect the formation of the second messen-
ger cGMP are compatible with this hypothesis.
It is of interest to note, however, that under the present in
vitro conditions ANP concentrations required to significantly
stimulate cGMP synthesis are substantially higher than ex-
pected from ligand binding determined K.
In order to further elucidate the potential roles of ANP
receptor subtypes we performed a second series of experi-
ments. Our original observation of a marked decrease in total
receptor number after chronic salt loading was confirmed by
our second series of experiments, using a modified method of
isolation of glomeruli involving acid wash as well as different
incubation buffer, incubation time and temperature. Under
these conditions, the down-regulation in total receptor number
was in the same range as in the first set of experiments, but
significantly higher total binding sites in both salt loaded and
control rats were detected.
A comparison of the two ANP binding methods revealed a
considerably lower binding at low concentrations of ANP when
incubated at 0°C without acid wash. Scatchard analysis of
binding data then resulted in nearly linear plots. Thus, this
method seems to be inappropriate to differentiate between a
heterogenous receptor population, that is, high affinity C- and
low affinity B-receptors. In a recently published study, Martin
et al [32] proposed that the apparent regulation of glomerular
ANP binding sites in response to an acute salt load (8 to 15
hours) or acute ANP infusion reflects occupancy of the 64 kDa
C-ANP receptor. This was concluded from the fact that the
decrease in total receptor number observed was abolished when
glomeruli were first exposed to an acid wash. In contrast,
Schiffrin, Gauquelin and Garcia [33] reported that prior recep-
tor occupancy does not explain decreased binding of ANP to
blood vessels or glomeruli in high plasma ANP states. This
conclusion resulted from a study on DOCA-salt hypertensive
rats and on uninephrectomized control rats. The decrease in
ANP binding to glomeruli of five weeks salt-loaded rats in our
study, however, was observed after prior acid treatment and
non-acid treatment of glomeruli from both salt-loaded and
control rats. In the absence of changes in plasma ANP-concen-
trations this fact strongly provides evidence for a specific role of
prolonged salt loading for ANP receptor down-regulation. In
our study about 40% of the estimated total receptors could be
blocked by cANP, a biologically inactive ANP analogue exclu-
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Fig. 4. ANP-stimulated cyclo-guanosine
monophosphate (cGMP) formation in freshly
isolated glomeruli from 7 rats after 35 days of
salt loading as compared to 7 control rats
(low sodium). A. Dose-dependent (I mm
incubation; N = 7) and B. Time-dependent
(ANP 106 M; N = 7) cGMP formation.
10 Symbols are: (•) low sodium; (0) high
sodium, () basal rate.ANP,M
0 2 4 6 8
Time, minutes
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sively binding to C-receptors. This is well in accordance with
results obtained by Martin et al reporting blockade of approx-
imately 50% of total glomerular ANP receptors by cANP [30,
32]. We observed that salt loading did not affect receptor
number in the presence of C-receptor blockade, that is, the
number of biologically active B-receptors was unaffected, while
their affinity was slightly decreased.
The decrease in binding sites in response to salt loading as
observed in our study, therefore, appears to be exclusively due
to a decrease in the number of C-receptor sites. Thus, the
decreased number of binding sites of glomerular clearance
receptors may indirectly result in a relatively greater quantity of
circulating ANP binding to biologically active glomerular and
postglomerular ANP receptors. Therefore, normal plasma ANP
concentrations may be sufficient to promote increased sodium
excretion in response to sodium chloride loading, since in the
presence of diminished ANP clearance, more ANP may escape
into the postglomerular circulation, being available for binding
to biologically active receptors at various tubular sites of the
nephron.
In summary, the observed changes in salt-induced glomerular
ANP receptor regulation may play a role in the homeostasis of
electrolyte and ECFV regulation. The mechanisms underlying
the different responses of the two types of glomerular ANP
receptors, namely of B- and C-receptors, to chronic salt loading
in the absence of changes in circulating ANP, cannot be
explained easily on the basis of our present results. More
detailed insight into ANP receptor regulation and its implica-
tions for the interactions of ANP with other endocrine systems
regulating the long-term homeostasis of body sodium and
ECFV awaits further investigations.
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